Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 3926-3931

  Tillmanns, Jochen ^a   Widera, Christian ^b   Habbaba, Yasmin ^b   Galuppo, Paolo ^b   Kempf, Tibor ^b   Wollert, Kai C ^b   Bauersachs, Johann ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Acute coronary syndrome; Biomarker; Fibroblast activation protein ; Inflammation; Mortality

Indexed keywords

SEPRASE; BIOLOGICAL MARKER; GELATINASE; MEMBRANE PROTEIN; SERINE PROTEINASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE THAWING; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; THERMOSTABILITY; BLOOD; CIRCULATION; FOLLOW UP; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD CIRCULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GELATINASES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; SERINE ENDOPEPTIDASES; YOUNG ADULT;

EID: 84886294605     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.061     Document Type: Article

References (24)

1. J.E. Park, M.C. Lenter, R.N. Zimmermann, P. Garin-Chesa, L.J. Old, and W.J. Rettig Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts J Biol Chem 274 1999 36505 36512
2. P. Garin-Chesa, L.J. Old, and W.J. Rettig Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers Proc Natl Acad Sci U S A 87 1990 7235 7239
3. H. Dolznig, N. Schweifer, and C. Puri Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin Cancer Immun 5 2005 10
4. J. Niedermeyer, M. Kriz, and F. Hilberg Targeted disruption of mouse fibroblast activation protein Mol Cell Biol 20 2000 1089 1094
5. P.S. Acharya, A. Zukas, V. Chandan, A.L. Katzenstein, and E. Pure Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis Hum Pathol 37 2006 352 360
6. M. Kraman, P.J. Bambrough, and J.N. Arnold Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha Science 330 2010 827 830
7. M.T. Levy, G.W. McCaughan, G. Marinos, and M.D. Gorrell Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection Liver 22 2002 93 101
8. S. Bauer, M.C. Jendro, and A. Wadle Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes Arthritis Res Ther 8 2006 R171
9. M. Jacob, L. Chang, and E. Pure Fibroblast activation protein in remodeling tissues Curr Mol Med 12 2012 1220 1243
10. P.J. Collins, G. McMahon, P. O'Brien, and B. O'Connor Purification, identification and characterisation of seprase from bovine serum Int J Biochem Cell Biol 36 2004 2320 2333
11. K.N. Lee, K.W. Jackson, V.J. Christiansen, C.S. Lee, J.G. Chun, and P.A. McKee Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein Blood 107 2006 1397 1404
12. D. Chen, A. Kennedy, and J.Y. Wang Activation of EDTA-resistant gelatinases in malignant human tumors Cancer Res 66 2006 9977 9985
13. F.M. Keane, N.A. Nadvi, T.W. Yao, and M.D. Gorrell Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-alpha FEBS J 278 2011 1316 1332
14. C.E. Brokopp, R. Schoenauer, and P. Richards Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata Eur Heart J 32 2011 2713 2722
15. Guideline for the preparation, use and quality assurance of blood (in German) 2010 Deutscher Aerzte-Verlag Cologne
16. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
17. A.S. Levey, J. Coresh, and T. Greene Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values Clin Chem 53 2007 766 772
18. S. Leicht, M. Shipkova, and C. Klett CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation Clin Biochem 2013 10.1016/j.clinbiochem.2013.04.006
19. M.J. Scanlan, B.K. Raj, and B. Calvo Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers Proc Natl Acad Sci U S A 91 1994 5657 5661
20. V.J. Christiansen, K.W. Jackson, K.N. Lee, and P.A. McKee The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity Blood 109 2007 5286 5292
21. N. Wild, H. Andres, and W. Rollinger A combination of serum markers for the early detection of colorectal cancer Clin Cancer Res 16 2010 6111 6121
22. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
23. B. Lindahl, H. Toss, A. Siegbahn, P. Venge, and L. Wallentin Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC study group. Fragmin during Instability in coronary artery disease N Engl J Med 343 2000 1139 1147
24. C. Heeschen, C.W. Hamm, V. Mitrovic, N.H. Lantelme, and H.D. White N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes Circulation 110 2004 3206 3212